Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Urinary Bladder Neoplasms × Synapsins × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urinary Bladder Neoplasms 1

Interventions

Gemcitabine 5 Cystectomy 5 Docetaxel 4 Drug Therapy 3 disitamab vedotin 2 Radiotherapy 2 Mitomycin 2 Cisplatin 2 vinflunine 1 toripalimab 1 penpulimab 1 nimotuzumab 1 entinostat 1 enfortumab vedotin 1 durvalumab 1 cemiplimab 1 Transurethral Resection of Bladder 1 Synapsins 1 Saline Solution 1 Radiosurgery 1 Paclitaxel 1 Olive Oil 1 Magnetic Resonance Spectroscopy 1 Liquid Biopsy 1 Injections 1 Immunoglobulin G 1 Epirubicin 1 Disulfides 1 Defecation 1 Conservative Treatment 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07332351 2026-03-13

TRIFECTA

University of Washington

Phase 2 Not yet recruiting

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡